- Home
- AMT vs BMY Comparison
AMT vs BMY Comparison
Compare AMT & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMT | BMY |
|---|---|---|
| Founded | 1995 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8B | 95.0B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMT | BMY |
|---|---|---|
| Price | $181.42 | $49.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 11 |
| Target Price | ★ $231.19 | $55.64 |
| AVG Volume (30 Days) | 2.9M | ★ 14.5M |
| Earning Date | 10-28-2025 | 10-30-2025 |
| Dividend Yield | 3.57% | ★ 5.04% |
| EPS Growth | ★ 164.45 | N/A |
| EPS | ★ 6.27 | 2.97 |
| Revenue | $10,454,700,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $5.31 | N/A |
| Revenue Next Year | $3.95 | N/A |
| P/E Ratio | $28.92 | ★ $16.56 |
| Revenue Growth | ★ 4.17 | 1.26 |
| 52 Week Low | $172.51 | $42.52 |
| 52 Week High | $234.33 | $63.33 |
Technical Indicators
Market Signals| Indicator | AMT | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 64.84 |
| Support Level | $178.50 | $45.27 |
| Resistance Level | $182.30 | $49.50 |
| Average True Range (ATR) | 3.58 | 1.14 |
| MACD | 0.44 | 0.19 |
| Stochastic Oscillator | 57.73 | 83.17 |
Price Performance
Historical ComparisonAbout AMT American Tower Corporation (REIT)
American Tower owns and operates about 150,000 wireless towers throughout the US, Asia, Latin America, Europe, and Africa. It also owns and/or operates 30 data centers in 11 US markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market generated by the top few mobile carriers. The company operates more than 40,000 towers in the US, which accounted for about half of total revenue in 2024. Outside the US, American Tower operates about 47,000 towers in Latin America (dominated by Brazil), 32,000 towers in Europe, and 27,000 towers in Africa. American Tower operates as a REIT.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.